What is Casimir?
Casimir is at the forefront of rare disease research, pioneering a new approach that leverages cutting-edge clinical trials. The company's methodology is designed to enhance the understanding of disease progression and to identify more effective treatment pathways. This focus positions Casimir as a key innovator in a critical area of medical science, aiming to address unmet needs in patient care.
How much funding has Casimir raised?
Casimir has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Casimir
PPP
Public-Private Partnership
What's next for Casimir?
The substantial late-stage funding Casimir has attracted signals a strong market validation and provides the necessary capital for scaling its operations and expanding its research initiatives. This strategic investment is expected to accelerate the development and implementation of its novel clinical trial strategies, potentially leading to breakthroughs in rare disease therapies. Casimir is poised to further solidify its leadership in this specialized field.
See full Casimir company page
